In silico off-target profiling for enhanced drug safety assessment by Jin Liu, Yike Gui, Jingxin Rao, Jingjing Sun, Gang Wang, Qun Ren, Ning Qu, Buying Niu, Zhiyi Chen, Xia Sheng, Yitian Wang, Mingyue Zheng, Xutong Li

Subjects: “…Drug safety…”
Get full text

Drug safety among institutionalized elderly people: potential interactions by Maria Lígia Silva Nunes Cavalcante, Renata Kelly Lopes de Alcântara, Isabelly Costa Lima de Oliveira, Samia Freitas Aires, Ana Lívia Araújo Girão, Rhanna Emanuela Fontenele Lima de Carvalho

Get full text

Drug Safety for Children — International Monitoring Data for 50 Years by B. K. Romanov, Yu. V. Olefir, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, L. I. Ilienko, S. P. Alpatov, N. V. Bogush, N. M. Buyanova, I. V. Ganshina, G. O. Dibirova, N. B. Dmitrieva, I. B. Zhukova, E. V. Kalinina, A. V. Kirillova, N. M. Kiseleva, G. V. Kukushkin, T. I. Leonteva, M. L. Maximov, E. V. Markina, S. E. Mileshina, D. E. Yurov

Get full text

Assessing drug safety by identifying the axis of arrhythmia in cardiomyocyte electrophysiology by Stewart Heitmann, Jamie I Vandenberg, Adam P Hill

Get full text

Application of morbid animal model in drug safety evaluation of TCM by Ning eKe-Yong, Li eMin

Get full text

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities by Elena V. Shubnikova, Marya A. Darmostukova, Irina I. Snegireva, Evgeniya O. Zhuravleva

Get full text

Monitoring post-approval drug safety in pregnancy: pharmacogenetic aspects

“…The purpose of this article is to describe and to examine the utility of new pharmacogenetic approaches in monitoring post-approval drug safety in pregnancy. Data on gene expression in pregnancy and metabolic variation may, in specific instances, help to predict adverse drug reactions in the mother-placenta-fetus complex and to identify individuals at a higher risk.…”
Get full text

Comparing epidemiological methods in detecting drug safety signal in IRAN by G Shalviri, K Mohammad, S.R Majdzadeh, K Gholami

Subjects: Get full text

Pharmacovigilance and assessment of drug safety reports during COVID 19 by Mira K Desai

“…To address the unmet medical need, the regulations are made flexible and convenient without any relaxation in drug safety reporting. The pharmacovigilance activities, especially adverse event reporting regardless of clinical trials or clinical practice should continue as usual because patient safety is the priority. …”
Get full text

Postmarketing Surveillance: Review of Open Sources of Drug Safety Data by E. V. Shubnikova

Subjects: “…adverse drug reaction, drug safety, regulatory authorities, postmarketing surveillance, postmarketing safety drug monitoring, benefit-risk assessment, postmarketing data sources, spontaneous reporting system, signal management, pharmacovigilance database, communications in pharmacovigilance…”
Get full text

Characteristics of drug safety alerts issued by the Spanish Medicines Agency by Eva Montané, Eva Montané, Javier Santesmases, Javier Santesmases

“…Objectives: To describe the characteristics of safety alerts issued by the Spanish Medicines Agency (AEMPS) and the Spanish Pharmacovigilance System over a 7-year period and the regulatory actions they generated.Methods: A retrospective analysis was carried out of drug safety alerts published on the AEMPS website from 1 January 2013 to 31 December 2019. …”
Get full text

What is the role of antineoplastic drug safety in reimbursement decision making? by A. S. Kolbin, A. A. Kurylev

Subjects: “…drug safety…”
Get full text

Systematic review of antiepileptic drugs’ safety and effectiveness in feline epilepsy by Marios Charalambous, Akos Pakozdy, Sofie F. M. Bhatti, Holger A. Volk

Get full text

Real-world evidence in antiretroviral therapy: drug safety data by Ana-Marta Silva, Marta Pereira, Cláudia Camila Dias, Ângela Ventura, Bernardo Sousa-Pinto

Get full text

Contribution of the Regional Drug Information Center Towards Drug Safety by Subish Palaian, P Mishra, PR Shankar, D Bista, B Pawar

“…Key Words: Drug information center, Drug information services, Drug related complications, Drug safety.…”
Get full text

Drug safety assessment in clinical trials: methodological challenges and opportunities by Singh Sonal, Loke Yoon K

“…Regulatory and academic partnerships should be fostered to provide an independent and transparent evaluation of drug safety.</p>…”
Get full text

Quantitative approaches to drug safety: The 2022 PSP special issue by Eric A. Sobie

Get full text

Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies by Zakir Khan, Yusuf Karatas, Ahmet Akici, Maria Auxiliadora Parreiras Martins, Nafees Ahmad

Get full text

Uncertainty characterisation in action potential modelling for cardiac drug safety by Johnstone, R

“…Following a workshop in July, 2013 at the US Food and Drug Administration (FDA), the <em>Comprehensive in-vitro Proarrhythmia Assay</em> (CiPA) initiative was proposed to improve safety testing, led by a number of drug safety and regulatory bodies around the world. …”

Weakened by strengths: drugs in solution, medication error and drug safety by Wheeler, D